Cryptococcus gattii: In vitro susceptibility to photodynamic inactivation

Photochemistry and Photobiology

Volumn 87, Issue 2, 2011, Pages 357-364

  Soares, Betânia Maria ^a,b   Alves, Orley Araújo ^a   Ferreira, Marcus Vinícius Lucas ^a   Amorim, José Cláudio Faria ^b   Sousa, Gerdal Roberto ^c   De Barros Silveira, Lívio ^c   Prates, Renato Araújo ^d   Ávila, Thiago Vinícius ^a   De Matos Baltazar, Ludmila ^a   Da Glória De Souza, Daniele ^a   Santos, Daniel Assis ^a   Modolo, Luzia Valentina ^a   Cisalpino, Patrícia Silva ^a   Pinotti, Marcos ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DE ITAÚNA   (Brazil)

^c FEAD   (Brazil)

^d INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCOCCUS GATTII;

EID: 79952120611     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2010.00868.x     Document Type: Article

References (53)

1. Chen, S., T. Sorrell, G. Nimmo, B. Speed, B. Currie, D. Ellis, D. Marriott, T. Pfeiffer, D. Parr, K. Byth, and Australasian Cryptococcal Study Group (2000) Epidemiology and host-and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin. Infect. Dis. 3, 499-508. (Pubitemid 32289583)
2. Speed, B., and, D. Dunt, (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21, 28-34.
3. Sorrell, T. C., (2001) Cryptococcus neoformans var. gattii. Med. Mycol. 39, 155-168.
4. Perfect, J. R., W. E. Dismukes, F. Dromer, D. L. Goldman, J. R. Graybill, R. J. Hamill, T. S. Harrison, R. A. Larsen, O. Lortholary, M.-H. Nguyen, P. G. Pappas, W. G. Powderly, N. Singh, J. D. Sobel, and, T. C. Sorrell, (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin. Infect. Dis. 50, 291-322.
5. Nishikawa, M. M., M. S. Lazera, G. G. Barbosa, L. Trilles, B. R. Balassiano, R. C. L. Macedo, C. C. F. Bezerra, M. A. Pérez, P. Cardarelli, and, B. Wanke, (2003) Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: Analysis of host and regional patterns. J. Clin. Microbiol. 41, 73-77. (Pubitemid 36098556)
6. Mendes, F. E. S., L. V. N. Oliveira, E. S. Faria, D. G. Alvarenga, M. R. Pinto, C. P. Taborda, B. M. Soares, P. S. Cisalpino, and, D. A. Santos, (2010) Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii. Eur. J. Clin. Microbiol. Infect. Dis. 29, 1525-1532.
7. Varma, A., and, K. J. Kwon-Chung, (2010) Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob. Agents Chemother. 54, 2303-2311.
8. Sar, B., D. Monchy, M. Vann, C. Keo, J. L. Sarthou, and, Y. Buisson, (2004) Increasing in vitro resistance to fluconazole in Cryptococcus neoformans cambodian isolates: April 2000 to March 2002. J. Antimicrob. Chemother. 54, 563-565. (Pubitemid 39177489)
9. Huang, Y. Y., A. C.-H. Chen, J. D. Carroll, and, M. R. Hamblin, (2009) Biphasic dose response in low level light therapy. Dose Response 7, 358-383.
10. Missall, T. A., J. K. Lodge, and, J. E. McEwen, (2004) Mechanisms of resistance to oxidative and nitrosative stress:Implications for fungal survival in mammalian hosts. Eukaryot. Cell 3, 835-846. (Pubitemid 39098859)
11. Plaetzer, K., B. Krammer, J. Berlanda, F. Berr, and, T. Kiesslich, (2009) Photophysics and photochemistry of photodynamic therapy: Fundamental aspects. Lasers Med. Sci. 24, 259-268.
12. Konan, Y. N., R. Gurny, and, E. Allémann, (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B 66, 89-106. (Pubitemid 34240266)
13. Zeina, B., J. Greenman, W. M. Purcell, and, B. Das, (2001) Killing of cutaneous microbial species by photodynamic therapy. British J. Dermol. 144, 274-278. (Pubitemid 32178805)
14. Smijs, T. G. M., J. A. Bouwstra, H. J. Schuitmaker, M. Talebi, and, S. Pavel, (2007) A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases. J. Antimicrob. Chemother. 59, 433-440. (Pubitemid 47073448)
15. Hamblin, M. R., and, T. Hasan, (2004) Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436-450. (Pubitemid 38855151)
16. Giroldo, L. M., M. P. Felipe, M. A. de Oliveira, E. Munin, L. P. Alves, and, M. S. Costa, (2009) Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med. Sci. 24, 109-112.
17. Szokalska, A., M. Makowski, D. Nowis, G. M. Wilczynski, M. Kujawa, C. Wojcik, I. Mynarczuk-Biay, P. Salwa, J. Bil, S. Janowska, P. Agostinis, T. Verfaillie, M. Bugajski, J. Gietka, T. Issat, E. Godkowska, P. Mrówka, T. Stoklosa, M. R. Hamblin, P. Mróz, M. Jakóbisiak, and, J. Golab, (2009) Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res. 69, 4235-4243.
18. Jackson, Z., S. Meghji, A. MacRobert, B. Henderson, and, M. Wilson, (1999) Killing of the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial agent. Lasers Med. Sci. 14, 150-157. (Pubitemid 29338652)
19. Clinical and Laboratory Standards Institute (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard (M27-A3), 3rd edn. Clinical and Laboratory Standards Institute, West Valley Road, Wayne, Pennsylvania.
20. Pfaller, M. A., L. Burmeister, M. S. Bartlett, and, M. G. Rinaldi, (1988) Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol. 26, 1437-1441.
21. Sampaio, I. B. M., (2002) Estatística Aplicada à Experimentação Animal, 2nd edn. FEPMVZ, Belo Horizonte.
22. Sakurada, H., H. Koizumi, A. Ohkawara, T. Ueda, and, N. Kamo, (1992) Use of dihydrorhodamine 123 for detecting intracellular generation of peroxides upon UV irradiation in epidermal keratinocytes. Arch. Dermatol. Res. 284, 114-116.
23. Cakmak, I., and, W. J. Horst, (1991) Effect of aluminium on lipid peroxidation, superoxide dismutase, catalase, and peroxidase activities in root tips of soybean (Glycine max). Physiol. Plant. 83, 463-468.
24. Boscolo, P. R. S., M. Menossi, and, R. A. Jorge, (2003) Aluminum-induced oxidative stress in maize. Phytochem. 62, 181-189. (Pubitemid 36857586)
25. Bradford, M. M., (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
26. Soares, B. M., D. A. Santos, L. M. Kohler, G. C. da César, I. R. de Carvalho, M. Dos, A. Martins, and, P. S. Cisalpino, (2008) Cerebral infection caused by Cryptococcus gattii: A case report and antifungal susceptibility testing. Rev. Iberoam. Micol. 25, 242-245.
27. Monfrecola, G., E. M. Procaccini, M. Bevilacqua, A. Manco, G. Calabrò, and, P. Santoianni, (2004) In vitro effect of 5-aminolaevulinic acid plus visible light on Candida albicans. Photochem. Photobiol. Sci. 3, 419-422. (Pubitemid 38855148)
28. Teichert, M., (2002) Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 93, 155-160. (Pubitemid 41115718)
29. Souza, S. C., J. C. Junqueira, I. Balducci, C. Y. Koga-Ito, E. Munin, and, A. O. Cardoso, (2006) Photosensitization of different Candida species by low power laser light. J. Photochem. Photobiol. B, Biol. 83, 34-38. (Pubitemid 43372640)
30. Strakhovskaya, M. G., N. S. Belenikina, E. V. Ivanova, Yu. K. Chemeris, and, E. F. Stranadko, (2002) The photodynamic inactivation of the yeast Candida guilliermondii in the presence of photodithazine. Microbiology 71, 345-348.
31. Bliss, M. J., C. E. Bigelow, T. H. Foster, and, C. G. Haidaris, (2004) Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob. Agents Chemother. 48, 2000-2006. (Pubitemid 38691589)
32. Â. Braz. J. Microbiol. 41, 42-49.
33. Tremblay, J.-F., S. Dussault, G. Viau, F. Gad, M. Boushira, and, R. Bissonnette, (2002) Photodynamic therapy with toluidine blue in Jurkat cells: Cytotoxicity, subcellular localization and apoptosis induction. Photochem. Photobiol. Sci. 1, 852-856. (Pubitemid 37069809)
34. Jori, G., and, G. Roncucci, (2006) Photodynamic therapy in microbial infections. Adv. Clin. Exp. Med. 15, 421-426. (Pubitemid 44083326)
35. Lambrechts, S. A. G., M. C. G. Aalders, and, J. Van Marle, (2005) Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphirin. Antimicrob. Agents Chemother. 49, 2026-2034. (Pubitemid 40631621)
36. Demidova, T. N., and, M. R. Hamblin, (2005) Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob. Agents Chemother. 49, 2329-2335. (Pubitemid 40734462)
37. Soares, B. M., D. L. Silva, G. R. Sousa, J. C. F. Amorim, M. A. Resende, M. Pinotti, and, P. S. Cisalpino, (2009) In vitro photodynamic inactivation of Candida spp. growth and adhesion to buccal epithelial cells. J. Photochem. Photobiol. B, Biol. 94, 65-70.
38. Prates, R. A., E. G. da Silva, A. M. Jr Yamada, L. C. Suzuki, C. R. Paula, and, M. S. Ribeiro, (2009) Light parameters influence cell viability in antifungal photodynamic therapy in a fluence and rate fluence-dependent manner. Laser Phys. 19, 1038-1044.
39. Qin, Y., X. Luan, L. Bi, G. He, X. Bai, C. Zhou, and, Z. Zhang, (2008) Toluidine blue-mediated photoinactivation of periodontal pathogens from supragingival plaques. Lasers Med. Sci. 23, 49-54. (Pubitemid 350196867)
40. Munin, E., L. M. Giroldo, L. P. Alves, and, M. S. Costa, (2007) Study of germ tube formation by Candida albicans after photodynamic antimicrobial chemotherapy (PACT). J. Photochem. Photobiol. B: Biol. 88, 16-20. (Pubitemid 47065246)
41. Prates, R. A., E. G. da Silva, P. F. Chaves, A. J. S. Santos, C. R. Paula, and, M. S. Ribeiro, (2010) Photodynamic therapy can kill Cryptococcus neoformans in vitro and in vivo models. Proc. SPIE. 7165, 71650H-1.
42. Peloi, L. S., R. R. S. Soares, C. E. G. Biondo, V. R. Souza, N. Hioka, and, E. Kimura, (2008) Photodynamic effect of light-emitting diode light on cell growth inhibition induced by methylene blue. J. Biosci. 33, 231-237. (Pubitemid 351840254)
43. Zámocký, M., P. G. Furtmüller, and, C. Obinger, (2009) Two distinct groups of fungal catalase/peroxidases. Biochem. Soc. Trans. 37, 772-777.
44. Fuchs, B. B., G. P. Tegos, M. R. Hamblin, and, E. Mylonakis, (2007) Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob. Agents Chemother. 51, 2929-2936. (Pubitemid 47206232)
45. Trilles, L., B. Fernández-Torres, M. S. Lazéra, B. Wanke, and, J. Guarro, (2004) In vitro antifungal susceptibility of Cryptococcus gattii. J. Clin. Microbiol. 42, 4815-4817. (Pubitemid 39362411)
46. Serena, C., B. Fernández-Torres, F. J. Pastor, L. Trilles, M. S. Lazéra, N. Nolard, and, J. Guarro, (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob. Agents Chemother. 49, 2994-2996. (Pubitemid 40917624)
47. Calvo, B. M., A. L. Colombo, O. Fischman, A. Santiago, L. Thompson, M. Lazera, F. Telles, K. Fukushima, K. Nishimura, R. Tanaka, M. Myiajy, and, M. L. Moretti-Branchini, (2001) Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J. Clin. Microbiol. 39, 2348-2350. (Pubitemid 32531513)
48. Souza, L. K. H., O. F. L. Fernandes, C. C. B. A. Kobayashi, X. S. Passos, C. R. Costa, J. A. Lemos, A. H. Souza-Júnior, and, M. R. R. Silva, (2005) Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil. Rev. Inst. Med. trop. S. Paulo. 47, 253-256. (Pubitemid 41565832)
49. Alves, S. H., L. T. Oliveira, J. M. Costa, I. Lubeck, A. K. Casali, and, M. H. Vainstein, (2001) In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in southern of Brazil. Rev. Inst. Med. trop. S. Paulo. 43, 267-270. (Pubitemid 33063714)
50. Fernandes, O. F. L., X. S. Passos, L. K. H. Souza, A. T. B. Miranda, C. H. P. V. Cerqueira, and, M. R. R. Silva, (2003) In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil. Mem. Inst. Oswaldo Cruz 98, 839-841. (Pubitemid 38019573)
51. Gomez-Lopez, A., M. Dos, A. Martins, M. C. Melhem, J. L. Rodriguez-Tudela, and, M. Cuenca-Estrella, (2008) In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin. Microbiol. Infect. 14, 727-730. (Pubitemid 351837036)
52. Morera-Lopez, Y., J. M. Torres-Rodríguez, T. Jiménez- Cabello, and, T. Baró-Tomás, (2005) Cryptococcus gattii: In vitro susceptibility to the new antifungal albazole versus fluconazole and voriconazole. Med. Mycol. 43, 505-510. (Pubitemid 41700943)
53. Iwata, K., T. Yamashita, M. Ohsumi, M. Baba, N. Naito, A. Taki, and, N. Yamada, (1990) Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutans of Cryptococcus neoformans. J. Med. Vet. Mycol. 28, 77-90. (Pubitemid 20308820)